Edition:
United States

People: Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,620.00GBp
5 Dec 2016
Change (% chg)

30.50p (+0.67%)
Prev Close
4,589.50p
Open
4,589.00p
Day's High
4,680.50p
Day's Low
4,585.00p
Volume
1,962,335
Avg. Vol
2,422,058
52-wk High
5,377.00p
52-wk Low
3,423.00p

Burns, William 

Mr. William Burns has been re-designated as Senior Non-Executive Independent Director of Shire Plc., effective 28 April 2016. He brings to the Board extensive international R&D, commercial, business development and operational experience in the pharmaceutical sector. He worked for Roche from 1986 until 2009; most recently holding the position of CEO of their pharmaceuticals division and serving as a member of the Roche Group Corporate Executive Committee. Bill holds a BA (Hons). Key appointments: Masters Pharmaceuticals (Chairman), Biotie Therapies Corp. (Chairman), Mesoblast Limited (Non-Executive Director), Vestergaard Frandsen (Vice Chairman), Wellcome Trust (Committee Chairman), Institute of Cancer Research (Trustee) and University of Cologne/Bonn Center for Integrated Oncology (Scientific Advisory Board Member).

Basic Compensation

Total Annual Compensation, GBP 125,250
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 125,250

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --